These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303 [TBL] [Abstract][Full Text] [Related]
30. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599 [TBL] [Abstract][Full Text] [Related]
31. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples. Angell TE; Wirth LJ; Cabanillas ME; Shindo ML; Cibas ES; Babiarz JE; Hao Y; Kim SY; Walsh PS; Huang J; Kloos RT; Kennedy GC; Waguespack SG Front Endocrinol (Lausanne); 2019; 10():612. PubMed ID: 31572297 [No Abstract] [Full Text] [Related]
32. Anchored multiplex PCR for targeted next-generation sequencing. Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085 [TBL] [Abstract][Full Text] [Related]
33. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662 [TBL] [Abstract][Full Text] [Related]
34. Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues. Sunami K; Furuta K; Tsuta K; Sasada S; Izumo T; Nakaoku T; Shimada Y; Saito M; Nokihara H; Watanabe S; Ohe Y; Kohno T J Thorac Oncol; 2016 Feb; 11(2):203-12. PubMed ID: 26845116 [TBL] [Abstract][Full Text] [Related]
35. Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay. Lyu X; Wang X; Zhang L; Chen Z; Zhao Y; Hu J; Fan R; Song Y Diagn Pathol; 2017 Jul; 12(1):55. PubMed ID: 28743306 [TBL] [Abstract][Full Text] [Related]
36. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib. Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703 [TBL] [Abstract][Full Text] [Related]
37. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples. Kurobe M; Kojima T; Nishimura K; Kandori S; Kawahara T; Yoshino T; Ueno S; Iizumi Y; Mitsuzuka K; Arai Y; Tsuruta H; Habuchi T; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Kakehi Y; Nagumo Y; Tsutsumi M; Oikawa T; Kikuchi K; Nishiyama H PLoS One; 2016; 11(12):e0165109. PubMed ID: 27930669 [TBL] [Abstract][Full Text] [Related]
38. Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer. Wagle MC; Castillo J; Srinivasan S; Holcomb T; Yuen KC; Kadel EE; Mariathasan S; Halligan DL; Carr AR; Bylesjo M; McAdam PR; Lynagh S; Marien KM; Kockx M; Waumans Y; Huang SA; Lackner MR; Mounir Z Cancer Immunol Res; 2020 Jul; 8(7):844-850. PubMed ID: 32321776 [TBL] [Abstract][Full Text] [Related]